SoniVie Raises $60m in Round C Financing, and Appoints New Board Members
By asianet
The funds, provided by new investors and current shareholder, will be used to support the Company clinical and regulatory path towards pre-market approval of its TIVUS(TM) technology for the treatment of hypertension SoniVie Ltd. (“SoniVie” or the “Company”), a medical device company developing a proprietary solution to treat hypertension, announced today the completion of a … Continued